Cargando…
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect
PURPOSE: Using CT findings from a prospective, randomized, open-label multicenter trial of favipiravir treatment of COVID-19 patients, the purpose of this study was to compare the utility of machine learning (ML)-based algorithm with that of CT-determined disease severity score and time from disease...
Autores principales: | Ohno, Yoshiharu, Aoyagi, Kota, Arakita, Kazumasa, Doi, Yohei, Kondo, Masashi, Banno, Sumi, Kasahara, Kei, Ogawa, Taku, Kato, Hideaki, Hase, Ryota, Kashizaki, Fumihiro, Nishi, Koichi, Kamio, Tadashi, Mitamura, Keiko, Ikeda, Nobuhiro, Nakagawa, Atsushi, Fujisawa, Yasuko, Taniguchi, Akira, Ikeda, Hirotaka, Hattori, Hidekazu, Murayama, Kazuhiro, Toyama, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993669/ https://www.ncbi.nlm.nih.gov/pubmed/35396667 http://dx.doi.org/10.1007/s11604-022-01270-5 |
Ejemplares similares
-
Response to RMED-D-22–00,258.R1
por: Ohno, Yoshiharu, et al.
Publicado: (2022) -
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
por: Doi, Yohei, et al.
Publicado: (2020) -
Favipiravir for symptomatic COVID-19: A nationwide observational cohort study
por: Doi, Yohei, et al.
Publicado: (2023) -
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
por: Doi, Kent, et al.
Publicado: (2020) -
State-of-the-art MR Imaging for Thoracic Diseases
por: Tanaka, Yumi, et al.
Publicado: (2021)